LL-37 LLG peptide
| Name | LL-37 LLG | ||||||
| Sequence | LLGDFFRKSKEKIGKEFKRIV | ||||||
| 3-letter-code | Leu - Leu - Gly - Asp - Phe - Phe - Arg - Lys - Ser - Lys - Glu - Lys - Ile - Gly - Lys - Glu - Phe - Lys - Arg - Ile - Val | ||||||
| Molecular weight | 2539.06 | ||||||
| Counter ion | TFA | ||||||
| Description | This LL-37 fragment corresponds to aa 134-154 of the human cationic antimicrobial protein 18 (hCAP18). | ||||||
| References | T Sigurdardottir, P Andersson, M Davoudi, M Malmsten, A Schmidtchen, M Bodelsson. 2006. In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37. Antimicrobial Agents and Chemotherapy 2006, p. 2983-2989 Vol. 50, No. 9 | ||||||
Order LL-37 LLG peptide
| Amount | Cat.No. | Unit price | |||||
|---|---|---|---|---|---|---|---|
| 1 mg | SP-LL37-LLG-1 | 350 EUR | BUY | ||||
| 5 mg | SP-LL37-LLG-5 | 740 EUR | BUY | ||||
| For larger amounts please inquire. | |||||||
LL-37 LLG antibody
Please inquire for pricing and availability.Related peptides
| Name | Sequence | ||||||
|---|---|---|---|---|---|---|---|
| Cys-LL-37 | CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| Cys-LL-37-Cys | CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | ||||||
| LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 (acetate) | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 : Ultra-pure | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 Citrulline | LLGDFF(Cit )KSKEKIGKE FK(Cit)IVQ (Cit)IKDFL (Cit)NLVP( Cit)TES | ||||||
| LL-37 FK-13 | FKRIVQRIKDFLR | ||||||
| LL-37 FKR | FKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 GKE | GKEFKRIVQRIKDFLRNLVPR | ||||||
| LL-37 KRI | KRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 RKS | RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 SKE | SKEKIGKEFKRIVQRIKDFLR | ||||||
| LL-37-Cys | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | ||||||
